4.8 Article

Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+T cell senescence via MiR-199a-5p/Sirt1/p53 axis

期刊

THERANOSTICS
卷 11, 期 2, 页码 893-905

出版社

IVYSPRING INT PUBL
DOI: 10.7150/thno.48080

关键词

Mesenchymal stem cells; Lupus; Senescence; Sirt1/p53; miR-199a-5p

资金

  1. Key Program of National Natural Science Foundation of China [81930043]
  2. Major International (Regional) Joint Research Project of China [81720108020]
  3. National Key Research and Development Program of China [2019YFA0802900]

向作者/读者索取更多资源

The study demonstrated that hUC-MSCs transplantation alleviated lupus symptoms and increased splenic CD4+ T cell senescence through the Sirt1/p53 pathway via miR-199a-5p in the MRL/lpr lupus mouse model, indicating a potential therapeutic mechanism for lupus disease.
Rationale: Although human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) transplantation has been proved to be an effective therapeutic approach to treat systemic lupus erythematosus (SLE), the detailed underlying mechanisms are not fully understood. Transferring miRNAs is one mean by which MSCs communicate with surrounding cells. Sirt1 is a NAD-dependent deacetylase that protects against cell senescence by deacetylating p53. Here we aimed to explore whether hUC-MSCs affected senescence of splenic CD4+ T cells through regulating Sirt1/p53 via miRNA in the MRL/lpr lupus mouse model. Methods: The effects of hUC-MSCs on lupus syndrome and senescence pathways in MRL/lpr mice in vivo and in vitro were determined. The functional roles of miR-199a-5p in splenic CD4+ T cell senescence were studied by miRNA mimic or inhibitor in vitro. MRL/lpr mice were injected with miR-199a-5p agomir to evaluate the effects of miR-199a-5p on splenic CD4+ T cell senescence and disease in vivo. Results: We showed that hUC-MSCs transplantation ameliorated lupus symptoms and increased senescence of splenic CD4+ T cells through Sirt1/p53 signaling via miR-199a-5p in MRL/lpr mice. Moreover, systemic delivery of miR-199a-5p in MRL/lpr mice increased splenic CD4+ T-cell senescence, mimicking the therapeutic effects of transplanted hUC-MSCs. Conclusions: We have identified miR-199a-5p as one of the mechanisms employed by hUC-MSCs to alleviate lupus disease associated pathologies in MRL/lpr mice, which is attributable for promoting splenic CD4+ T cell senescence through Sirt1/p53 pathway.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据